{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:39:40Z","timestamp":1775147980963,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["9473"],"award-info":[{"award-number":["9473"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["9473"],"award-info":[{"award-number":["9473"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fogarty International Centre of the National Institutes of Health","award":["D43TW010345"],"award-info":[{"award-number":["D43TW010345"]}]},{"name":"Fogarty International Centre of the National Institutes of Health","award":["D43TW010345"],"award-info":[{"award-number":["D43TW010345"]}]},{"name":"Fogarty International Centre of the National Institutes of Health","award":["D43TW010345"],"award-info":[{"award-number":["D43TW010345"]}]},{"name":"University of Cape Town"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    South Africa has a high burden of human immune deficiency virus (HIV)-associated Hodgkin lymphoma (HL) which is typically Epstein\u2013Barr virus (EBV) infected, detected by histological stains. Circulating plasma EBV derived from apoptotic EBV infected tumour cells is a potential biomarker. This study aimed to evaluate the role of plasma EBV load testing in newly diagnosed HL patients\u00a0and correlate pretreatment plasma EBV levels, HIV status and EBV tumour status with overall survival (OS). Untreated HL patients were prospectively included. Polymerase chain reaction measured EBV plasma viral loads. Kaplan\u2013Meier curves with log-rank tests estimated the impact of HIV, EBV tumour status and plasma EBV viral loads on OS. Multivariable analysis was performed using a Cox proportional hazards model. Receiver operative characteristic curve analysis determined cutoff plasma EBV DNA levels with optimal sensitivity, specificity and concordance with tumour EBV status. The 68 patients included 21 (31%) HIV +ve and 33 (49%) EBV tumour +ve. EBV plasma \u2265\u200910 000\u00a0IU\/ml (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.008), EBV +ve tumour (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.014), HIV +ve status (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.009) and age \u2265\u200945\u00a0years (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.018) predicted poorer OS on univariate analysis. Plasma EBV levels &gt;\u2009762\u00a0IU\/ml had 89.29% sensitivity and 96.77% specificity for detecting EBV +ve HL. High plasma EBV levels \u2265\u200910 000\u00a0IU\/ml, HIV +ve status and EBV tumour +ve status predicted poorer OS. Plasma EBV levels &gt;\u2009762\u00a0IU\/ml predicted EBV +ve tumour status with high sensitivity and specificity. Plasma EBV viral DNA testing is a promising biomarker for EBV +ve HL.\n                  <\/jats:p>","DOI":"10.1007\/s10238-024-01524-8","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:42:16Z","timestamp":1732621336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hodgkin lymphoma: the role of EBV plasma viral load testing in an HIV-endemic setting"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-2604","authenticated-orcid":false,"given":"J.","family":"Opie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-4231","authenticated-orcid":false,"given":"Z.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-2180","authenticated-orcid":false,"given":"D.","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7181-3015","authenticated-orcid":false,"given":"J.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6132-4717","authenticated-orcid":false,"given":"K.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4657-7318","authenticated-orcid":false,"given":"E.","family":"Verburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0056-7547","authenticated-orcid":false,"given":"D.","family":"Hardie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"1524_CR1","unstructured":"UNAIDS. Global HIV and AIDS statistics\u2014fact sheet 2023 2 November 2023."},{"issue":"22","key":"1524_CR2","first-page":"2145","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS. HIV-associated cancers and related diseases. N Engl J Med. 2018;378(22):2145.","journal-title":"N Engl J Med"},{"issue":"3","key":"1524_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/ijlh.12782","volume":"40","author":"L Phillips","year":"2018","unstructured":"Phillips L, Opie J. The utility of bone marrow sampling in the diagnosis and staging of lymphoma in South Africa. Int J Lab Hematol. 2018;40(3):276\u201383.","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"1524_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/QAI.0000000000002768","volume":"88","author":"T Wiggill","year":"2021","unstructured":"Wiggill T, Mayne E, Perner Y, Vaughan J. Changing patterns of lymphoma in the antiretroviral therapy era in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2021;88(3):252\u201360.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"1524_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00277-018-3533-0","volume":"98","author":"L Swart","year":"2019","unstructured":"Swart L, Novitzky N, Mohamed Z, Opie J. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration. Ann Hematol. 2019;98(2):381\u20139.","journal-title":"Ann Hematol"},{"key":"1524_CR6","doi-asserted-by":"publisher","first-page":"e2100163","DOI":"10.1200\/GO.21.00163","volume":"8","author":"K Moahi","year":"2022","unstructured":"Moahi K, Ralefala T, Nkele I, Triedman S, Sohani A, Musimar Z, et al. HIV and Hodgkin lymphoma survival: a prospective study in Botswana. JCO Glob Oncol. 2022;8:e2100163.","journal-title":"JCO Glob Oncol"},{"issue":"5","key":"1524_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.pathol.2020.11.004","volume":"53","author":"K Antel","year":"2021","unstructured":"Antel K, Chetty D, Oosthuizen J, Mohamed Z, Van der Vyver L, Verburgh E. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients. Pathology. 2021;53(5):628\u201334.","journal-title":"Pathology"},{"issue":"1","key":"1524_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/COH.0000000000000333","volume":"12","author":"A Carbone","year":"2017","unstructured":"Carbone A, Volpi CC, Gualeni AV, Gloghini A. Epstein-Barr virus associated lymphomas in people with HIV. Curr Opin HIV AIDS. 2017;12(1):39\u201346.","journal-title":"Curr Opin HIV AIDS"},{"issue":"13","key":"1524_CR9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350(13):1328\u201337.","journal-title":"N Engl J Med"},{"key":"1524_CR10","unstructured":"Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues: international agency of research on cancer. 2017."},{"issue":"18","key":"1524_CR11","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","volume":"121","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Li H, Gellert LL, Lemas MV, Hsieh WS, Hong F, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood. 2013;121(18):3547\u201353.","journal-title":"Blood"},{"issue":"11","key":"1524_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1182\/bloodadvances.2016002618","volume":"1","author":"JJG Welch","year":"2017","unstructured":"Welch JJG, Schwartz CL, Higman M, Chen L, Buxton A, Kanakry JA, et al. Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma. Blood Adv. 2017;1(11):681\u20134.","journal-title":"Blood Adv"},{"issue":"16","key":"1524_CR13","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","volume":"127","author":"JA Kanakry","year":"2016","unstructured":"Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007\u201317.","journal-title":"Blood"},{"issue":"2","key":"1524_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1634\/theoncologist.2018-0058","volume":"24","author":"WS Liang","year":"2019","unstructured":"Liang WS, Vergilio JA, Salhia B, Huang HJ, Oki Y, Garrido-Laguna I, et al. Comprehensive genomic profiling of Hodgkin lymphoma reveals recurrently mutated genes and increased mutation burden. Oncologist. 2019;24(2):219\u201328.","journal-title":"Oncologist"},{"key":"1524_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fonc.2019.00062","volume":"9","author":"H Kimura","year":"2019","unstructured":"Kimura H, Kwong YL. EBV viral loads in diagnosis, monitoring, and response assessment. Front Oncol. 2019;9:62.","journal-title":"Front Oncol"},{"issue":"12","key":"1524_CR16","doi-asserted-by":"publisher","first-page":"e0189033","DOI":"10.1371\/journal.pone.0189033","volume":"12","author":"MK Smatti","year":"2017","unstructured":"Smatti MK, Yassine HM, AbuOdeh R, AlMarawani A, Taleb SA, Althani AA, et al. Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. PLoS ONE. 2017;12(12):e0189033.","journal-title":"PLoS ONE"},{"issue":"7","key":"1524_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/00002030-200205030-00005","volume":"16","author":"SJ Stevens","year":"2002","unstructured":"Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS. 2002;16(7):993\u20131001.","journal-title":"AIDS"},{"key":"1524_CR18","doi-asserted-by":"publisher","first-page":"1276138","DOI":"10.3389\/fonc.2023.1276138","volume":"13","author":"A Alberti","year":"2023","unstructured":"Alberti A, Stocker G, Lordick F, Hacker UT, Kobitzsch B, Haffner I, et al. Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study). Front Oncol. 2023;13:1276138.","journal-title":"Front Oncol"},{"issue":"4","key":"1524_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00432-024-05702-9","volume":"150","author":"J Chen","year":"2024","unstructured":"Chen J, Zhou J, Cheng F, Chen D, Guan F, Zhang E, et al. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma. J Cancer Res Clin Oncol. 2024;150(4):181.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18","key":"1524_CR20","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1182\/blood-2013-02-484451","volume":"121","author":"RM Meyer","year":"2013","unstructured":"Meyer RM. EBV DNA: a Hodgkin lymphoma biomarker? Blood. 2013;121(18):3541\u20132.","journal-title":"Blood"},{"issue":"4","key":"1524_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12032-018-1099-2","volume":"35","author":"I Ul-Haq","year":"2018","unstructured":"Ul-Haq I, Dalla Pria A, Suardi E, Pinato DJ, Froeling F, Forni J, et al. Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma. Med Oncol. 2018;35(4):53.","journal-title":"Med Oncol"},{"issue":"6","key":"1524_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/QAD.0000000000002129","volume":"33","author":"J Lupo","year":"2019","unstructured":"Lupo J, Germi R, Lancar R, Algarte-Genin M, Hendel-Chavez H, Taoufik Y, et al. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era. AIDS. 2019;33(6):993\u20131000.","journal-title":"AIDS"},{"issue":"1","key":"1524_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jinf.2020.11.027","volume":"82","author":"S Yu","year":"2021","unstructured":"Yu S, Yang Q, Wu J, Zhu M, Ai J, Zhang H, et al. Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: a cohort study. J Infect. 2021;82(1):105\u201311.","journal-title":"J Infect"},{"issue":"2","key":"1524_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ijc.33802","volume":"150","author":"Z Shen","year":"2022","unstructured":"Shen Z, Hu L, Yao M, He C, Liu Q, Wang F, et al. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: a retrospective multicenter study in Huaihai lymphoma working group. Int J Cancer. 2022;150(2):327\u201334.","journal-title":"Int J Cancer"},{"issue":"1","key":"1524_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cll.2017.10.007","volume":"38","author":"T Tomoka","year":"2018","unstructured":"Tomoka T, Montgomery ND, Powers E, Dhungel BM, Morgan EA, Mulenga M, et al. Lymphoma and pathology in Sub-Saharan Africa: current approaches and future directions. Clin Lab Med. 2018;38(1):91\u2013100.","journal-title":"Clin Lab Med"},{"issue":"5","key":"1524_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.biologicals.2016.04.010","volume":"44","author":"JF Fryer","year":"2016","unstructured":"Fryer JF, Heath AB, Wilkinson DE, Minor PD. A collaborative study to establish the 1st WHO international standard for Epstein-Barr virus for nucleic acid amplification techniques. Biologicals. 2016;44(5):423\u201333.","journal-title":"Biologicals"},{"key":"1524_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ctrv.2019.06.002","volume":"77","author":"JM Zaucha","year":"2019","unstructured":"Zaucha JM, Chauvie S, Zaucha R, Biggii A, Gallamini A. The role of PET\/CT in the modern treatment of Hodgkin lymphoma. Cancer Treat Rev. 2019;77:44\u201356.","journal-title":"Cancer Treat Rev"},{"issue":"27","key":"1524_CR28","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059\u201368.","journal-title":"J Clin Oncol"},{"key":"1524_CR29","doi-asserted-by":"publisher","first-page":"1034398","DOI":"10.3389\/fonc.2022.1034398","volume":"12","author":"J Hu","year":"2022","unstructured":"Hu J, Zhang X, Tao H, Jia Y. The prognostic value of Epstein-Barr virus infection in Hodgkin lymphoma: a systematic review and meta-analysis. Front Oncol. 2022;12:1034398.","journal-title":"Front Oncol"},{"key":"1524_CR30","doi-asserted-by":"publisher","first-page":"106607","DOI":"10.1016\/j.leukres.2021.106607","volume":"107","author":"JQ Qin","year":"2021","unstructured":"Qin JQ, Yin H, Wu JZ, Chen RZ, Xia Y, Wang L, et al. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma. Leuk Res. 2021;107:106607.","journal-title":"Leuk Res"},{"issue":"10310","key":"1524_CR31","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","volume":"398","author":"P Brice","year":"2021","unstructured":"Brice P, de Kerviler E, Friedberg JW. Classical Hodgkin lymphoma. Lancet. 2021;398(10310):1518\u201327.","journal-title":"Lancet"},{"issue":"2","key":"1524_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41375-020-0875-0","volume":"35","author":"J Driessen","year":"2021","unstructured":"Driessen J, Visser O, Zijlstra JM, Lugtenburg PJ, Plattel WJ, Kersten MJ, et al. Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989\u20132017. Leukemia. 2021;35(2):494\u2013505.","journal-title":"Leukemia"},{"issue":"4","key":"1524_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/QAD.0000000000003456","volume":"37","author":"K Antel","year":"2023","unstructured":"Antel K, Oosthuizen J, Brown K, Malherbe F, Loebenberg P, Seaton C, et al. Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis and HIV-endemic region. AIDS. 2023;37(4):587\u201394.","journal-title":"AIDS"}],"updated-by":[{"DOI":"10.1007\/s10238-025-02025-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000}}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01524-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01524-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01524-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:11:09Z","timestamp":1769137869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01524-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01524-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to formatting error in Table 1 of the article","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10238-025-02025-y","URL":"https:\/\/doi.org\/10.1007\/s10238-025-02025-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"10"}}